Dynavax Technologies | Lånekapital

Loan Capital Endring Dato
AbbVie USD 63.81B 8.17B 2024-03
Adma Biologics USD 130.85M 253K 2024-03
Amgen USD 60.06B 3.11B 2024-03
AstraZeneca USD 27.26B 4.04B 2024-03
Biogen USD 6.29B 498.1M 2024-03
BioMarin Pharmaceutical USD 593.6M 510K 2024-03
Bristol-Myers Squibb USD 49.49B 17.35B 2024-03
Dynavax Technologies USD 222.98M 286K 2024-03
Gilead Sciences USD 21.53B 1.66B 2024-03
Glaxosmithkline GBP 15.2B 788M 2023-12
Merck USD 31.14B 2.83B 2024-03
Neurocrine Biosciences USD 169.5M 500K 2023-03
Novartis USD 17.19B 2.84B 2024-03
Pfizer USD 60.48B 571M 2024-03
Regeneron Pharmaceuticals USD 1.98B 719.6M 2024-03
Roche Holding CHF 24.81B 4.46B 2023-12
Sarepta Therapeutics USD 1.13B 103.1M 2024-03
TG Therapeutics USD 101.33M 2.42M 2024-03



Dynavax Technologies Lånekapital - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Jun 2024.